Ganli Pharmaceutical: Xute Hongda plans to reduce its stake in the company by 0.57%

Jin10 data reported on July 4th, Ganli Pharmaceutical announced in the evening that Xutohongda and its concerted action party, Gan Zhongru, collectively hold 40.11% of the company’s shares, of which Xutohongda holds 5.90%. Xutohongda plans to reduce its holdings by no more than 3,399,500 shares through centralized bidding transactions within 3 months after the announcement date, accounting for 0.57% of the company’s total share capital. Jiao Jiao plans to reduce its holdings by no more than 67,500 shares, accounting for 0.0112% of the company’s total share capital. Sun Cheng plans to reduce its holdings by no more than 20,000 shares, accounting for 0.0033% of the company’s total share capital. This reduction plan will not affect the company’s governance structure or ongoing operations.